Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2020 Filed Mar 2, 2020 22:44 UTC |
Quigley Jill M.Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 211,001 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014677 · doc4.xml · derivative · entry 1 Quigley Jill M. · CIK 0001799780 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,001 Underlying: Common Stock · 211,001 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 17:49 UTC |
Romano GaryChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 74,311 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014688 · doc4.xml · derivative · entry 1 Romano Gary · CIK 0001799779 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,311 Underlying: Common Stock · 74,311 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 17:46 UTC |
Morris Richard StevenChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 74,311 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014685 · doc4.xml · derivative · entry 1 Morris Richard Steven · CIK 0001432303 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,311 Underlying: Common Stock · 74,311 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 18:03 UTC |
Yamada TadatakaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014704 · doc4.xml · derivative · entry 1 Yamada Tadataka · CIK 0001402530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 17:42 UTC |
SQUINTO STEPHEN PDirector · Head of Research and Dev
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014671 · doc4.xml · derivative · entry 2 SQUINTO STEPHEN P · CIK 0001231954 · Director · Head of Research and Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F2 · derivative.exercise_date: The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 17:42 UTC |
SQUINTO STEPHEN PDirector · Head of Research and Dev
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 185,776 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014671 · doc4.xml · derivative · entry 1 SQUINTO STEPHEN P · CIK 0001231954 · Director · Head of Research and Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,776 Underlying: Common Stock · 185,776 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:54 UTC |
Heron Patrick JDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014695 · doc4.xml · derivative · entry 1 Heron Patrick J · CIK 0001365617 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:58 UTC |
Ratcliffe LiamDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014700 · doc4.xml · derivative · entry 1 Ratcliffe Liam · CIK 0001547100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 23:05 UTC |
Countouriotis AthenaDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014706 · doc4.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:55 UTC |
Islam SaqibDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 16,918 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014697 · doc4.xml · derivative · entry 1 Islam Saqib · CIK 0001575408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,918 Underlying: Common Stock · 16,918 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 18:01 UTC |
Woiwode ThomasDirector · 10% owner
|
GrantDirector Stock Option (Right to Buy) · Derivative | 33,836 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014702 · doc4.xml · derivative · entry 1 Woiwode Thomas · CIK 0001619294 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,836 Underlying: Common Stock · 33,836 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:56 UTC |
Kapadia SandipDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 16,918 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014698 · doc4.xml · derivative · entry 1 Kapadia Sandip · CIK 0001677141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,918 Underlying: Common Stock · 16,918 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:52 UTC |
Cale Edgar B.GC and Corporate Secretary
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 99,731 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014694 · doc4.xml · derivative · entry 1 Cale Edgar B. · CIK 0001799783 · GC and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,731 Underlying: Common Stock · 99,731 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:50 UTC |
Fotopoulos AlexandrosChief Technical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 74,311 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014691 · doc4.xml · derivative · entry 1 Fotopoulos Alexandros · CIK 0001799814 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,311 Underlying: Common Stock · 74,311 shares Expires 2030-02-27 F1 · derivative.exercise_date: The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.